The hormone secretion in pancreatic neuroendocrine tumors (pNET) causes an important interference in patients' quality of life. We present two cases of pNET metastatic to the liver (a pancreatic endocrine carcinoma with a severe hormonal syndrome and an insulinoma with severe crisis of hypoglycemia and coma) refractory to conventional treatments, which were finally solved with selective internal radiation therapy (SIRT), a nonstandard level 1 therapy. We show two examples of an excellent control of symptoms together with a long survival after treatment with SIRT. The evidence supporting the use of this therapy is level 2. Our case reports strongly support the use of SIRT for the severe clinical syndrome in pNET metastatic to the liver and refractory to somatostatin analogs.
Keyphrases
- neuroendocrine tumors
- radiation therapy
- end stage renal disease
- case report
- early onset
- small cell lung cancer
- oxidative stress
- squamous cell carcinoma
- ischemia reperfusion injury
- ejection fraction
- type diabetes
- chronic kidney disease
- newly diagnosed
- polycystic ovary syndrome
- public health
- peritoneal dialysis
- drug induced
- radiation induced
- locally advanced
- metabolic syndrome
- molecular docking
- stem cells
- patient reported outcomes
- skeletal muscle
- molecular dynamics simulations
- weight loss
- smoking cessation
- free survival